Lauren Larocca, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-955-5000 |
Dr. Satish Potluri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4644 |
Dr. Saritha Gorantla, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-720-8695 Fax: 410-720-8580 |
Vanessa Rodis Ruales, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-720-8695 |
Muhammad Hamza Bukhari, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890 |
Manjul Sharma, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6740 Alexander Bell Dr # 300, Columbia, MD 21046 Phone: 410-564-0000 Fax: 410-564-0032 |
Rafeena Bacchus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5900 Waterloo Rd Ste 200, Columbia, MD 21045 Phone: 410-740-2900 Fax: 410-992-0732 |
William O Webber, RPA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-955-5000 |
Mohammed Mehboob, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 11055 Little Patuxent Pkwy Ste 104, Columbia, MD 21044 Phone: 410-740-2900 |
Imelda Celestine Udo, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Columbia, MD 21044 Phone: 410-910-2330 |
Mrs. Navkiran Kaur Brar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4644 |
News Archive
Morinaga Milk Industry Co., Ltd., a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).
Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
Less than 10 per cent of paediatric patients who suffer a cardiac arrest outside of the hospital survive. There are many factors which can influence survival rates; paramedic care is one of them.
Chronic myelomonocytic leukemia (CMML) is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes and less than 20 percent blasts. CMML has few treatment options and patients only survive on average for 12 to 24 months.
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with localized prostate cancer. Prolaris is the first and only biopsy test validated against prostate cancer specific mortality.
› Verified 2 days ago